HOME  CONSUMERS
  HEALTHCARE
  PROFESSIONALS		  RESEARCHERS
  ABOUT US
Features/News

VAP Test Helps Researchers Uncover Best Cholesterol Lowering Treatment for Type II Diabetes
LEARN MORE

Atherotech VAP Cholesterol Test
Meets Updated ADA, ACC Measurement and Treatment Guidelines for High
Risk Patients
LEARN MORE


THE VAP TEST
TREATMENT GUIDE
CASE HISTORIES
CLINICAL UPDATES
LITERATURE &
PUBLICATIONS
WELLNESS PARTNERS
HOMOCYSTEINE
& CRP TESTS
EVENTS
NEWS
CME
LICENSES &
ACCREDITATIONS

Case Histories & Patient Profiles

Case Histories

Methodist Hospital Laboratory Adopts the VAP Cholesterol Test pdf


Patient Profiles

David Hape, age 58, discovered that 65% of his arteries were blocked after the VAP Test showed more detailed information on his HDL subclass information.

 

 

Bobbi Rowenczak, age 48, was prescribed N-acetylcysteine after her doctor found out her lipid subclass of LDL showed elevated Lp(a) which doesn’t respond to traditional cholesterol-lowering therapies.

 

 

Lanse Hyde, age 57, was a marathon runner who discovered that even with good diet and exercise, his LDL needed aggressive medical treatment.
Home | Contact Us | Privacy Policy |  © 2008 Atherotech